Estrella Immunopharma, Inc. (ESLA): auditor change — Estrella Immunopharma dismisses Marcum as auditor, appoints MGO for FY2024

Estrella Immunopharma, Inc.

Marcum LLP dismissed as independent auditor effective Jan 30, 2024; no disagreements with Marcum.
Marcum's audit report for FY2023 included a going concern explanatory paragraph.
Macias Gini & O'Connell (MGO) appointed as new auditor for fiscal year ending June 30, 2024.
No consultations with MGO on accounting principles or disagreements prior to engagement.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Estrella Immunopharma, Inc. engaged Macias Gini & O’Connell, LLP as its auditor.

Action: engagement
Auditor: Macias Gini & O’Connell, LLP

Exact text from the filing

appointed Macias Gini & O’Connell, LLP ("MGO") as the Company’s new independent registered public accounting firm for the fiscal year ending June 30, 2024, effective as of January 30, 2024.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Estrella Immunopharma, Inc. dismissed Marcum LLP as its auditor.

Action: dismissal
Auditor: Marcum LLP
Successor: Macias Gini & O’Connell, LLP

Exact text from the filing

dismissed its independent registered public accountant Marcum LLP ("Marcum"), effective as of January 30, 2024.

View on SEC.gov

Browse all auditor changes →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-009325

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.